Skip to main content
ACHCAcadia Healthcare Company, Inc.Sell5.4·$37.94
SellModerate Confidence

Thesis pillars

  • Thin Cash Margins Weak Quality↓Deteriorating
  • Price Above Analyst Target↓Deteriorating
  • Medicaid Payer Concentration↓Deteriorating
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Nov 8, 2026, based on the 10-K filed Feb 27, 2026

Full reasoning →

Open full analysis

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis

SellVALUE-TRAP 1/5GrowthModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $37.94: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: High short interest: 32%; Elevated put/call ratio: 1.60; Below-average business quality.

Acadia Healthcare operates 277 behavioral healthcare facilities with over 12,500 beds across 40 states and Puerto Rico through acute inpatient psychiatric, specialty treatment, comprehensive treatment center, and residential programs. Revenue totaled $3,312.8 million in 2025,... Read more

$37.94-10.4% A.UpsideScore 5.4/10#21 of 35 Medical Care Facilities
QualityF-score8 / 9FCF yield0.93%
Stop $35.28Analyst target $33.99(reached)A.R:R -0.7:1
Analyst consensus$39.07+3.0%14 analysts with price targets
$37.94price
$39.07mean
$19
$46

Sell if holding. Engine safety override at $37.94: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: High short interest: 32%; Elevated put/call ratio: 1.60; Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.4/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 98d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated Nov 10, 2026

Recent Developments — Acadia Healthcare Company, Inc.

Latest item Nov 10, 2026 · Generated 2026-11-18T11:47:22Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Feb 24, 202798d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Customer: Medicaid (57.7%)
Target reached (-10.4% upside)
Quality below floor (3.6 < 4.0)

Key Metrics

P/E (TTM)—
P/E (Fwd)18.6
Mkt Cap$3.5B
EV/EBITDA11.4
Profit Mgn-33.1%
ROE-40.5%
Rev Growth5.1%
Beta0.63
DividendNone
Analysts with ratings20

Quality Signals

Piotroski F8/9

Options Flow

P/C1.60bearish
IV52%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomerMedicaid58%
    10-K Item 1: 'we received 57.7% of our revenue from Medicaid, 24.6% from commercial payors, 14.3% from Medicare and 3.4% from other payors'
  • MEDIUMGeographicPennsylvania, California and Tennessee
    10-K Item 1A: 'we have substantial operations in Pennsylvania, California and Tennessee, which makes us especially sensitive to regulatory, economic, environmental and competitive conditions'

Material Events(8-K, last 90d)

  • 2026-04-23Item 5.02MEDIUM
    CFO Todd Young resigned effective April 30, 2026. David M. Duckworth appointed Interim CFO and principal financial officer effective May 1, 2026. Duckworth previously served as Acadia CFO from July 2012 to July 2023. No disagreement cited.
    SEC filing →
  • 2026-03-12Item 5.02LOW
    Director Wade Miquelon announced retirement from the Board effective at the 2026 Annual Meeting; will not stand for reelection. Daniel Cancelmi appointed as new Class III director, joining the Audit Committee. No disagreement cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Growth Rank
3.5
Value Rank
5.3

Unprofitable operations — net margin -33.1%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Roa
2.3
Fcf Quality
3.2
Operating Margin
3.9
Gross Margin
4.2
Moat
4.4
Current Ratio
5.8
Piotroski F
8.9
FCF-positive but moderate margins (FCF margin 1%, FCF yield 0.9%)No competitive moatStrong Piotroski F-Score: 8/9
GatesA.R:R -0.7=NEGATIVEMomentum 5.2<5.5 (soft — BUY_NOW allowed but watch)Executive change: officer departure/appointmentMomentum 5.2>=4.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 98d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
83 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $28.89Resistance $39.70

Price Targets

A.Upside-10.4%
A.R:R-0.7:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeSteady

Risk Alerts

! Target reached (-10.4% upside)
! Quality below floor (3.6 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2027-02-24 (98d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ACHC stock a buy right now?

Sell if holding. Engine safety override at $37.94: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: High short interest: 32%; Elevated put/call ratio: 1.60; Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $35.28. Score 5.4/10, moderate confidence.

What is the ACHC stock price target?

Analyst target $33.99 reached (−10.4% from $37.94); no take-profit level is published. Prior stop was $35.28. Stop-loss: $35.28.

What are the risks of investing in ACHC?

Concentration risk — Customer: Medicaid (57.7%); Target reached (-10.4% upside); Quality below floor (3.6 < 4.0).

Is ACHC overvalued or undervalued?

Acadia Healthcare Company, Inc. trades at a P/E of N/A (forward 18.6). TrendMatrix value score: 6.9/10. Verdict: Sell.

What do analysts say about ACHC?

20 analysts rate ACHC, with a consensus score of 3.8/5. 14 analysts publish price targets averaging $39.

What does Acadia Healthcare Company, Inc. do?Acadia Healthcare operates 277 behavioral healthcare facilities with over 12,500 beds across 40 states and Puerto Rico...

Acadia Healthcare operates 277 behavioral healthcare facilities with over 12,500 beds across 40 states and Puerto Rico through acute inpatient psychiatric, specialty treatment, comprehensive treatment center, and residential programs. Revenue totaled $3,312.8 million in 2025, with 57.7% from Medicaid, 24.6% from commercial payors, and 14.3% from Medicare.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · SRTA (Strata Critical Medical, Inc.) · NUTX (Nutex Health Inc.) · ARDT (Ardent Health, Inc.) · DVA (DaVita Inc.)
Home › Stocks › ACHC

Latest news

Latest News

Fiscal.ai8d ago
Fiscal.ai9d agoAnalyst
Fiscal.ai12d agoAnalyst
Fiscal.ai12d ago
Benzinga12d ago
Benzinga12d agoAnalyst
Fiscal.ai12d agoAnalyst
Fiscal.ai12d agoAnalyst
Benzinga12d agoAnalyst
Fiscal.ai13d agoAnalyst
Fiscal.ai13d ago
Benzinga13d agoAnalyst
Benzinga13d agoEarnings
Benzinga13d ago
Fiscal.ai13d agoEarnings
Fiscal.ai13d ago
Fiscal.ai14d ago
Benzinga14d agoEarnings
Benzinga14d ago
Fiscal.ai15d ago
Loading more...